Cargando…

BENEFIT AND SAFETY OF INCOBOTULINUMTOXINA FOR EARLY MANAGEMENT OF POST-STROKE SPASTICITY IN A PATIENT WITH SARS-COV-2: A CASE REPORT

OBJECTIVE: To describe a case of early management of post-stroke spasticity treated with incobotulinumtoxinA (IncoA) in a patient with SARS-CoV-2 (COVID-19). Scarce information is available on this subject, as the COVID-19 pandemic has necessitated postponement of interventions in infected and clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cordero-GarcÍa, Carlos, SÁEnz De Tejada SÁnchez, María del Mar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Foundation for Rehabilitation Information 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215229/ https://www.ncbi.nlm.nih.gov/pubmed/34276907 http://dx.doi.org/10.2340/20030711-1000065

Ejemplares similares

Randomized, placebo‐controlled trial of incobotulinumtoxina for upper‐limb post‐stroke spasticity
por: Elovic, Elie Paul, et al.
Publicado: (2015)

Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
por: Santamato, Andrea
Publicado: (2016)

Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects
por: Masakado, Yoshihisa, et al.
Publicado: (2022)

SUSTAINED EFFICACY OF INCOBOTULINUMTOXINA FOLLOWING REPEATED INJECTIONS FOR UPPER-LIMB POST-STROKE SPASTICITY: A POST HOC ANALYSIS
por: KAŇOVSKÝ, Petr, et al.
Publicado: (2020)

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study
por: Wissel, Jörg, et al.
Publicado: (2017)

Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis
por: Berweck, Steffen, et al.
Publicado: (2022)

Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis
por: Kaňovský, Petr, et al.
Publicado: (2021)

IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy – a retrospective case series focusing on dosing and tolerability
por: León-Valenzuela, Angel, et al.
Publicado: (2020)

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
por: Fheodoroff, Klemens, et al.
Publicado: (2020)

Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE)
por: Masakado, Yoshihisa, et al.
Publicado: (2020)

IncobotulinumtoxinA for Post-stroke Upper Limb Spasticity in Neutralizing Antibody-positive Patients after Botulinum Toxin Therapy: A Report of Two Cases
por: Masakado, Yoshihisa, et al.
Publicado: (2022)

IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study
por: Marciniak, Christina, et al.
Publicado: (2018)

“Appropriate Treatment” and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units
por: Ianieri, Giancarlo, et al.
Publicado: (2018)

Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
por: Wissel, Jörg, et al.
Publicado: (2021)

Safety and efficacy of repeat long-term incobotulinumtoxinA treatment for lower limb or combined upper/lower limb spasticity in children with cerebral palsy
por: Kaňovský, Petr, et al.
Publicado: (2022)

IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study(1)
por: Heinen, Florian, et al.
Publicado: (2021)

Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study
por: Dressler, Dirk, et al.
Publicado: (2015)

Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm
por: Truong, Daniel D., et al.
Publicado: (2013)

Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults
por: Jost, Wolfgang H., et al.
Publicado: (2023)

Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia
por: Dressler, Dirk, et al.
Publicado: (2013)

Spasticity-related pain in children/adolescents with cerebral palsy. Part 2: IncobotulinumtoxinA efficacy results from a pooled analysis
por: Bonfert, Michaela, et al.
Publicado: (2023)

Profile of Xeomin(®) (incobotulinumtoxinA) for the treatment of blepharospasm
por: Park, Juwan, et al.
Publicado: (2011)

IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
por: Yutskovskaya, Yana, et al.
Publicado: (2015)

New insights into the pathophysiology of post-stroke spasticity
por: Li, Sheng, et al.
Publicado: (2015)

Bilateral Motor Cortex tDCS Effects on Post-Stroke Pain and Spasticity: A Three Cases Study
por: Molero-Chamizo, Andrés, et al.
Publicado: (2021)

A Literature Review on the Efficacy and Safety of Botulinum Toxin: An Injection in Post-Stroke Spasticity
por: Ghasemi, Majid, et al.
Publicado: (2013)

Effectiveness and safety of acupuncture for post-stroke spasticity: A systematic review and meta-analysis
por: Xue, Chen, et al.
Publicado: (2022)

Improving the Management of Post-Stroke Spasticity: Time for Action
por: Christofi, Gerry, et al.
Publicado: (2018)

EARLY BRAIN IMAGING PREDICTORS OF POST-STROKE SPASTICITY
por: RI, Songjin, et al.
Publicado: (2021)

Role of Spasticity Severity in the Balance of Post-stroke Patients
por: Mahmoudzadeh, Ashraf, et al.
Publicado: (2021)

Emerging theory of sensitization in post-stroke muscle spasticity
por: Suputtitada, Areerat
Publicado: (2023)

IncobotulinumtoxinA Injection for Treating Children with Idiopathic Toe Walking: A Retrospective Efficacy and Safety Study
por: Filippetti, Mirko, et al.
Publicado: (2022)

A PRACTICAL GUIDE TO OPTIMIZING THE BENEFITS OF POST-STROKE SPASTICITY INTERVENTIONS WITH BOTULINUM TOXIN A: AN INTERNATIONAL GROUP CONSENSUS
por: FRANCISCO, Gerard E., et al.
Publicado: (2020)

High Doses of Botulinum Toxin Type A for the Treatment of Post-Stroke Spasticity: Rationale for a Real Benefit for the Patients
por: Santamato, Andrea
Publicado: (2022)

Quantitative Ultrasound to Assess Skeletal Muscles in Post Stroke Spasticity
por: Tran, Anthony, et al.
Publicado: (2021)

Effect of post-stroke spasticity on voluntary movement of the upper limb
por: Lackritz, Hadar, et al.
Publicado: (2021)

Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders
por: Jost, Wolfgang H, et al.
Publicado: (2015)

Placebo-Controlled Clinical Trial of IncobotulinumtoxinA for Sialorrhea in Children: SIPEXI
por: Berweck, Steffen, et al.
Publicado: (2021)

Efficacy and safety of whole-body vibration therapy for post-stroke spasticity: A systematic review and meta-analysis
por: Zhang, Qi, et al.
Publicado: (2023)

Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia
por: Fernandez, Hubert H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cbgrbl8aned5l7uqoqhhmaq9f3